Anat Iosub-Amir

Anat Iosub-Amir, PhD, is an experienced professional currently serving as a Board Observer at CytoReason and OncoHost, while also holding the position of Board Member at Sweetch, Mermade Seafoods, and POLARISqb. Since July 2021, Anat has been with OurCrowd, progressing through roles from Junior Investment Analyst to Investment Director. Additionally, Anat is a member of Global Women in VC and WE@HealthTech. Academic achievements include a PhD in Chemistry and an MBA in BioMed from The Hebrew University of Jerusalem, with honors in both fields.